Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Read More 5 minute read Pharma Industry News What makes gene-editing tools like CRISPR 3.0 the next frontier in precision medicine? Delve into the next generation of gene-editing tools, such as prime editing, and see how they may revolutionize precision medicine – read more now! byPallavi MadhirajuSeptember 16, 2025